bit.bio
Human cell models reprogrammed from stem cells at scale
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
bit.bio is a Cambridge, UK synthetic biology company whose opti-ox technology reprograms human stem cells into specific cell types precisely, consistently and at scale. Its ioCells human cell models are used in drug discovery, disease research, functional genomics and toxicology. In November 2026 bit.bio announced a $25 million Series D, with participation from existing investor M&G Investments, to expand its cell-model portfolio.
- Website
- bit.bio
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- ioCells — Consistent human iPSC-derived cell models for research · Other